Pomanda estimates the enterprise value of NOBLEGEN CRYOGENICS LTD at £753.6k based on a Turnover of £1.1m and 0.68x industry multiple (adjusted for size and gross margin).
noblegen cryogenics ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of NOBLEGEN CRYOGENICS LTD at £0 based on an EBITDA of £-770.9k and a 3.84x industry multiple (adjusted for size and gross margin).
noblegen cryogenics ltdEstimated Valuation
£1.4m
Pomanda estimates the enterprise value of NOBLEGEN CRYOGENICS LTD at £1.4m based on Net Assets of £687.2k and 2.1x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Noblegen Cryogenics LtdOverview
Noblegen Cryogenics Ltd is a live company located in boldon colliery, NE35 9LZ with a Companies House number of 02624327. It operates in the manufacture of electric motors, generators and transformers sector, SIC Code 27110. Founded in June 1991, it's largest shareholder is
dusty tlp limited
with a 100% stake. Noblegen Cryogenics Ltd is a mature,
small sized company, Pomanda has estimated its turnover at
£1.1m with
declining
growth in recent years.
Pomanda's financial health check has awarded Noblegen Cryogenics Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
2 Strong
3 Regular
7 Weak
Size
annual sales of £1.1m, make it smaller than the average company (£19.5m)
£1.1m - Noblegen Cryogenics Ltd
£19.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -23%, show it is growing at a slower rate (10.8%)
-23% - Noblegen Cryogenics Ltd
10.8% - Industry AVG
Production
with a gross margin of 16%, this company has a higher cost of product (24.5%)
16% - Noblegen Cryogenics Ltd
24.5% - Industry AVG
Profitability
an operating margin of -69.8% make it less profitable than the average company (4.2%)
-69.8% - Noblegen Cryogenics Ltd
4.2% - Industry AVG
Employees
with 11 employees, this is below the industry average (110)
11 - Noblegen Cryogenics Ltd
110 - Industry AVG
Pay Structure
on an average salary of £51.9k, the company has an equivalent pay structure (£51.9k)
£51.9k - Noblegen Cryogenics Ltd
£51.9k - Industry AVG
Efficiency
resulting in sales per employee of £101k, this is less efficient (£202.5k)
£101k - Noblegen Cryogenics Ltd
£202.5k - Industry AVG
Debtor Days
it gets paid by customers after 56 days, this is near the average (65 days)
56 days - Noblegen Cryogenics Ltd
65 days - Industry AVG
Creditor Days
its suppliers are paid after 119 days, this is slower than average (46 days)
119 days - Noblegen Cryogenics Ltd
46 days - Industry AVG
Stock Days
it holds stock equivalent to 255 days, this is more than average (93 days)
255 days - Noblegen Cryogenics Ltd
93 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 58 weeks, this is more cash available to meet short term requirements (10 weeks)
58 weeks - Noblegen Cryogenics Ltd
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 61%, this is a similar level of debt than the average (62.7%)
61% - Noblegen Cryogenics Ltd
62.7% - Industry AVG
NOBLEGEN CRYOGENICS LTD financials
EXPORT
Noblegen Cryogenics Ltd's latest turnover from March 2024 is estimated at £1.1 million and the company has net assets of £687.2 thousand. According to their latest financial statements, Noblegen Cryogenics Ltd has 11 employees and maintains cash reserves of £663.1 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Turnover
1,111,044
2,322,238
2,733,386
2,444,865
2,487,960
2,007,327
1,522,919
1,768,692
1,517,124
1,826,770
1,515,251
1,285,519
1,472,898
1,017,803
911,857
783,545
Other Income Or Grants
Cost Of Sales
932,909
1,972,850
2,288,346
2,041,227
2,121,604
1,616,579
1,227,014
1,390,401
1,260,922
1,442,609
1,222,027
1,075,384
1,223,394
781,282
683,076
583,326
Gross Profit
178,134
349,388
445,040
403,638
366,356
390,747
295,905
378,291
256,202
384,161
293,224
210,135
249,504
236,521
228,781
200,219
Admin Expenses
953,152
458,320
-29,465
-198,629
65,263
222,343
234,713
191,033
152,991
356,948
266,852
224,169
174,073
138,929
143,598
140,695
Operating Profit
-775,018
-108,932
474,505
602,267
301,093
168,404
61,192
187,258
103,211
27,213
26,372
-14,034
75,431
97,592
85,183
59,524
Interest Payable
3,400
5,246
2,506
1,360
1,360
1,020
1,094
1,094
760
780
Interest Receivable
30,017
20,715
10,181
506
343
1,759
1,358
16
25
234
32
89
804
Pre-Tax Profit
-748,402
-93,463
482,180
601,412
300,075
170,163
61,530
186,180
102,142
27,448
26,404
-13,945
74,671
97,592
85,987
58,744
Tax
-91,614
-114,268
-57,014
-32,331
-11,691
-26,057
-4,808
-5,489
-5,545
-8,522
-17,798
-15,073
-12,605
Profit After Tax
-748,402
-93,463
390,566
487,144
243,061
137,832
49,839
160,123
97,334
21,958
20,859
-13,945
66,149
79,794
70,914
46,139
Dividends Paid
90,330
71,660
71,060
65,160
63,710
65,160
Retained Profit
-748,402
-93,463
390,566
487,144
243,061
137,832
49,839
69,793
25,674
21,958
20,859
-13,945
-4,911
14,634
7,204
-19,021
Employee Costs
570,706
560,938
512,780
445,328
508,395
491,194
468,587
297,318
296,374
326,136
286,156
247,056
241,296
166,014
161,903
Number Of Employees
11
12
12
11
12
12
12
8
8
9
8
7
7
5
5
EBITDA*
-770,884
-99,004
481,011
608,018
308,266
170,804
63,593
190,305
105,611
30,288
29,117
-10,734
82,290
105,453
88,783
69,139
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Tangible Assets
114,873
118,113
126,621
110,097
115,848
120,007
122,607
125,008
128,055
130,455
133,530
96,275
99,575
106,534
111,525
115,125
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
114,873
118,113
126,621
110,097
115,848
120,007
122,607
125,008
128,055
130,455
133,530
96,275
99,575
106,534
111,525
115,125
Stock & work in progress
653,526
417,421
214,154
819,560
61,000
39,116
Trade Debtors
172,155
1,167,197
1,377,101
1,071,601
816,234
411,038
376,740
147,728
439,004
381,676
328,212
364,914
313,011
198,941
139,981
Group Debtors
Misc Debtors
159,057
161,017
317,179
27,076
63,048
15,513
38,163
25,777
12,905
4,893
5,415
Cash
663,097
480,400
308,745
596,255
415,011
270,849
198,123
163,891
217,496
80,909
12,742
12
35,451
8,662
21,202
417
misc current assets
total current assets
1,647,835
2,226,035
2,217,179
1,694,932
1,294,293
1,090,409
609,161
556,144
403,387
519,913
394,418
389,224
426,142
334,578
225,036
184,929
total assets
1,762,708
2,344,148
2,343,800
1,805,029
1,410,141
1,210,416
731,768
681,152
531,442
650,368
527,948
485,499
525,717
441,112
336,561
300,054
Bank overdraft
44,594
30,211
21,587
156,597
109,184
68,946
Bank loan
10,000
11,104
22,741
5,161
Trade Creditors
305,848
382,801
498,064
383,623
522,176
755,238
402,689
329,360
268,223
440,151
329,039
425,233
445,115
179,522
106,438
120,102
Group/Directors Accounts
17,252
6,290
28,677
7,018
other short term finances
hp & lease commitments
other current liabilities
257,020
489,506
251,181
206,504
154,394
36,439
16,300
32,745
40,208
57,672
total current liabilities
590,120
883,411
771,986
590,127
721,164
755,238
402,689
396,010
306,110
440,151
329,039
425,233
445,115
375,154
284,507
258,899
loans
17,952
21,396
38,019
72,678
hp & lease commitments
Accruals and Deferred Income
other liabilities
75,438
36,191
45,060
56,793
62,695
83,237
93,888
16,104
22,495
provisions
467,479
3,782
4,773
1,008
1,474
1,867
1,867
1,867
1,867
1,867
1,866
1,866
1,866
2,639
3,369
1,549
total long term liabilities
485,431
25,178
42,792
76,446
37,665
46,927
58,660
64,562
74,545
85,104
95,754
17,970
24,361
2,639
3,369
1,549
total liabilities
1,075,551
908,589
814,778
666,573
758,829
802,165
461,349
460,572
380,655
525,255
424,793
443,203
469,476
377,793
287,876
260,448
net assets
687,157
1,435,559
1,529,022
1,138,456
651,312
408,251
270,419
220,580
150,787
125,113
103,155
42,296
56,241
63,319
48,685
39,606
total shareholders funds
687,157
1,435,559
1,529,022
1,138,456
651,312
408,251
270,419
220,580
150,787
125,113
103,155
42,296
56,241
63,319
48,685
39,606
Mar 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Operating Activities
Operating Profit
-775,018
-108,932
474,505
602,267
301,093
168,404
61,192
187,258
103,211
27,213
26,372
-14,034
75,431
97,592
85,183
59,524
Depreciation
4,134
9,928
6,506
5,751
7,173
2,400
2,401
3,047
2,400
3,075
2,745
3,300
6,859
7,861
3,600
9,615
Amortisation
Tax
-91,614
-114,268
-57,014
-32,331
-11,691
-26,057
-4,808
-5,489
-5,545
-8,522
-17,798
-15,073
-12,605
Stock
236,105
203,267
214,154
-819,560
819,560
-61,000
61,000
-39,116
39,116
Debtors
-997,002
-366,066
595,603
219,395
879,282
-411,038
18,785
206,362
-253,113
57,328
53,464
-62,479
64,775
122,082
58,438
145,396
Creditors
-76,953
-115,263
114,441
-138,553
-233,062
352,549
73,329
61,137
-171,928
111,112
-96,194
-19,882
265,593
73,084
-13,664
120,102
Accruals and Deferred Income
-232,486
238,325
44,677
52,110
154,394
-36,439
20,139
16,300
-32,745
-7,463
-17,464
57,672
Deferred Taxes & Provisions
463,697
-991
3,765
-466
-393
1
-773
-730
1,820
1,549
Cash flow from operations
144,271
185,866
-257,477
187,446
112,469
82,500
70,007
39,162
198,288
78,584
-65,086
-29,137
241,068
30,464
25,080
51,345
Investing Activities
capital expenditure
-894
-1,420
-23,030
-3,014
200
-40,000
100
-2,870
-124,740
Change in Investments
cash flow from investments
-894
-1,420
-23,030
-3,014
200
-40,000
100
-2,870
-124,740
Financing Activities
Bank loans
-1,104
-11,637
22,741
-5,161
5,161
Group/Directors Accounts
17,252
-6,290
-22,387
21,659
7,018
Other Short Term Loans
Long term loans
-3,444
-16,623
38,019
-72,678
72,678
Hire Purchase and Lease Commitments
other long term liabilities
-75,438
39,247
-8,869
-11,733
-5,902
62,695
-83,237
-10,651
77,784
-6,391
22,495
share issue
40,000
-2,167
1,875
58,627
interest
26,617
15,469
7,675
-854
-1,017
1,759
338
-1,078
-1,069
234
32
89
-760
804
-780
cash flow from financing
39,321
-12,791
-7,003
38,393
-9,886
-9,974
-5,564
-11,061
-11,628
-10,417
117,816
-6,302
13,278
-22,387
19,177
70,026
cash and cash equivalents
cash
182,697
171,655
-287,510
181,244
144,162
72,726
34,232
-53,605
136,587
68,167
12,730
-35,439
26,789
-12,540
20,785
417
overdraft
-44,594
44,594
-30,211
8,624
21,587
-156,597
47,413
40,238
68,946
change in cash
182,697
171,655
-287,510
225,838
99,568
72,726
64,443
-62,229
115,000
68,167
12,730
-35,439
183,386
-59,953
-19,453
-68,529
noblegen cryogenics ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for noblegen cryogenics ltd. Get real-time insights into noblegen cryogenics ltd's credit score, group structure and payment trends.
Perform a competitor analysis for noblegen cryogenics ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in NE35 area or any other competitors across 12 key performance metrics.
noblegen cryogenics ltd Ownership
NOBLEGEN CRYOGENICS LTD group structure
Noblegen Cryogenics Ltd has no subsidiary companies.
The sole shareholder of Noblegen Cryogenics Ltd is Dusty Tlp Limited.
dusty tlp limited
100%
noblegen cryogenics ltd directors
Noblegen Cryogenics Ltd currently has 3 directors.
The longest serving directors include
Mr Robert Henderson Macgeachy (Feb 2024) and
Mr Alastair Dickson (Feb 2024).
unit 6 brooklands way, boldon business park, boldon colliery, NE35 9LZ
Bank
BARCLAYS BANK PLC
Legal Advisor
-
noblegen cryogenics ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 9 charges/mortgages relating to noblegen cryogenics ltd. Currently there are 0 open charges and 9 have been satisfied in the past.
noblegen cryogenics ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NOBLEGEN CRYOGENICS LTD. This can take several minutes, an email will notify you when this has completed.
noblegen cryogenics ltdCompanies House Filings - See Documents
